Yueming He
No. 248-252 Dongjie Street
Quanzhou, 362000, China
Quanzhou, 362000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Plasma EGFR mutation ctDNA dynamics in patients with advanced EGFR-mutated NSCLC treated with Icotinib: phase 2 multicenter trial result.
Journal: Scientific reports
Published: July 17, 2024
Case report: Favorable efficacy of combined afatinib and anlotinib treatment in a lung adenocarcinoma patient harboring uncommon EGFR L858M/L861R mutations.
Journal: Frontiers in pharmacology
Published: May 23, 2024
The effect of afatinib in a pretreated patient with invasive mucinous adenocarcinoma of the lung harboring HER2 YVMA insertion: a case report.
Journal: Translational cancer research
Published: May 17, 2022
Concordance of Genomic Profiles in Matched Tissue and Plasma Samples From Chinese Patients With Lung Cancer.
Journal: Clinical Medicine Insights. Oncology
Published: March 20, 2022
The diagnostic value of D-dimer with simplified Geneva score (SGS) pre-test in the diagnosis of pulmonary embolism (PE).
Journal: Journal of cardiothoracic surgery
Published: December 30, 2019
Different Types of ROS1 Fusion Partners Yield Comparable Efficacy to Crizotinib.
Journal: Oncology research
Published: April 04, 2019
Correlated low IGF2BP1 and FOXM1 expression predicts a good prognosis in lung adenocarcinoma.
Journal: Pathology, research and practice
Published: January 15, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026